Summary & Overview
HCPCS Q4415: Alexiguard topical per square centimeter (add-on)
HCPCS Level II code Q4415 denotes the per-square-centimeter billing for Alexiguard, a topical dermatologic product billed as an add-on in addition to a primary procedure. This code matters nationally as it standardizes reporting for adjunctive topical treatments used in dermatologic and minor surgical settings, affecting coding accuracy, reimbursement bundling, and clinical documentation workflows. Key payers included in the national context are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find an overview of what the code represents, common clinical scenarios where a per-area topical product is used, and the implications for claims submission when Q4415 is reported as an add-on. The publication summarizes payer coverage patterns, coding best practices for documentation (unitization per square centimeter), and related billing considerations such as add-on reporting alongside primary procedural codes. It also highlights benchmark items and any recent policy updates or guidance that affect national billing and reimbursement for per-area topical dermatologic products. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code Q4415 represents Alexiguard sl-t, per square centimeter (add-on, list separately in addition to primary procedure). This code is used to report the application of a topical skin treatment product (Alexiguard) on a per-square-centimeter basis when it is billed in addition to a primary procedure.
Service Type: Topical dermatologic product application (per unit area)
Typical Site of Service: Outpatient clinic or ambulatory surgical center where dermatologic procedures or topical treatments are performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
Service: Q4415 (Alexiguard sl-t, per square centimeter, add-on)
A typical patient is an adult with a non-melanoma skin cancer (e.g., squamous cell carcinoma in situ or basal cell carcinoma) or a chronic wound requiring topical, localized application of a proprietary biologic or diagnostic agent applied to the skin surface during a dermatologic procedure. The clinical workflow begins in an outpatient dermatology clinic or ambulatory surgery center. The patient presents for lesion evaluation and treatment; after topical or local anesthesia is provided, the clinician performs the primary procedure (for example, lesion debridement, excision, or a diagnostic application). Q4415 is billed as an add-on per square centimeter for the application of the Alexiguard product to the treatment site. Typical sites of service include dermatology offices, ambulatory surgery centers, and hospital outpatient departments. The patient encounter includes measurement of the treated surface area in square centimeters, documentation of product lot/quantity applied, and correlation to the primary procedure and diagnosis. Common clinical scenarios include adjunctive topical therapy after tumor debulking, localized application for wound bed preparation, or use during diagnostic topical testing in office-based dermatologic care.
Coding Specifications
- Modifier tables and provider taxonomies below reflect commonly used CMS modifiers and typical provider specialties relevant to an add-on, per-area topical product such as
Q4415.
| Modifier |
|---|